Vivimed Labs shines on obtaining new product registration

12 Feb 2018 Evaluate

Vivimed Labs is currently trading at Rs. 87.00, up by 1.55 points or 1.81% from its previous closing of Rs. 85.45 on the BSE.

The scrip opened at Rs. 85.15 and has touched a high and low of Rs. 88.45 and Rs. 85.15 respectively. So far 75601 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 153.30 on 21-Sep-2017 and a 52 week low of Rs. 75.00 on 06-Feb-2018.

Last one week high and low of the scrip stood at Rs. 89.45 and Rs. 75.00 respectively. The current market cap of the company is Rs. 718.78 crore.

The promoters holding in the company stood at 35.81%, while Institutions and Non-Institutions held 10.14% and 54.05% respectively.

Vivimed Labs’ Unit 1 FDF manufacturing facility located in Hyderabad, post certification by Ukraine FDA, has successfully registered 8 products in anti viral, pain management and cough suppressants segment.

The company has now inked a distribution agreement with ‘Alter Ego LLC’, Kieve, Ukraine which has more than a decade of presence in Ukraine, Russia and CIS regions. The company is expecting revenues upwards of $10 million for FY19 from CIS region.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.


Vivimed Labs Share Price

5.75 0.00 (0.00%)
31-Jul-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×